(Q40246541)

18 September 2017

title

A series of unconjugated ferrocenyl phenols: prospects as anticancer agents (English)

1 reference

18 September 2017

1

1 reference

18 September 2017

4

1 reference

18 September 2017

7

1 reference

18 September 2017

Anne Vessières

2

1 reference

18 September 2017

Franck Le Bideau

series ordinal

3

1 reference

18 September 2017

Daniela Spera

series ordinal

5

1 reference

18 September 2017

Michel Huché

series ordinal

6

1 reference

18 September 2017

publication date

1 May 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

1

1 reference

18 September 2017

issue

5

1 reference

18 September 2017

page(s)

551-559

1 reference

The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Tumour-inhibiting platinum complexes--state of the art and future perspectives.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Non-platinum chemotherapeutic metallopharmaceuticals

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Gallium in cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Ferricenium complexes: a new type of water-soluble antitumor agent

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Water stability and cytotoxic activity relationship of a series of ferrocenium derivatives. ESR insights on the radical production during the degradation process.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Ferrocene-induced lymphocyte activation and anti-tumor activity is mediated by redox-sensitive signaling

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Complexes of dichloro[2-(dimethylaminomethyl)phenyl-C1,N]gold(III), [Au(damp-C1,N)Cl2], with formylferrocene thiosemicarbazones: synthesis, structure and cytotoxicity.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Synthesis of benzyl- and benzhydrylferrocenes via Friedel–Crafts alkylation of ferrocene. Access to ferrocenyl bisphenols with high affinities for estrogen receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Bis(4-hydroxyphenyl)[2-(phenoxysulfonyl)phenyl]methane: isolation and structure elucidation of a novel estrogen from commercial preparations of phenol red (phenolsulfonphthalein)

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Estrogenic effect of a series of bisphenol analogues on gene and protein expression in MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Synthesis and evaluation of 11beta-substituted 21-chloro/iodo-(17alpha,20E/Z)-19-norpregna-1,3,5(10),20-te traene-3, 17beta-diols: high-affinity ligands for the estrogen receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Ferrocene-Mediated Proton-Coupled Electron Transfer in a Series of Ferrocifen-Type Breast-Cancer Drug Candidates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

The effects of aromatic substituents on the chromatographic enantioseparation of diarylmethyl esters with the whelk-O1 chiral stationary phase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Organometallic estrogens: synthesis, interaction with lamb uterine estrogen receptor, and detection by infrared spectroscopy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

11.beta.-Methoxy-, 11.beta.-ethyl, and 17.alpha.-ethynyl-substituted 16.alpha.-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

ROS stress in cancer cells and therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Mitochondrial localization of estrogen receptor beta

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500035

7 January 2021

Identifiers

DOI

10.1002/CMDC.200500035

1 reference

18 September 2017

1 reference